Politics
Friday July 23, 2004
Pharmaceutical tries again for FDA Approval of Morning After Pill Without Prescription
TODAY'S HEADLINES
E-MAIL
PRINT
WASHINGTON, July 23, 2004 (LifeSiteNews.com) - This May, the Food and Drug Administration rejected nonprescription sales of emergency contraception, in the midst of controversy. Now the manufacturer of the abortifacient drug is again pressuring the US government to allow its sale without a prescription. The FDA decision left a loophole when they said they might reconsider if the company, Barr Pharmaceuticals, could show some way of guaranteeing that the drug will only be sold without prescription to girls and women over 16.
In their letter to Barr, the FDA said that there would have to be some means of selling the product as both a prescription-only and non-prescription drug and to educate the public as to the difference. The mixed marketing approach is called a 'novelty' in the letter and the FDA has never before approved such a scheme. A spokesman for Barr said that the legal counsel has found a way to comply with the FDA stipulations. "We are pleased to be responding to the FDA with a submission that we believe will lead to approval of use of Plan B emergency contraceptive as an over-the-counter product for women 16 and older will maintain the availability of Plan B as a prescription-only product for women age 15 years and younger," said Dr. Carole Ben-Maimon, President and COO of Barr Research.
ph
Back to TopLatest Headlines
- BREAKING: US Congress Passes Health Care Reform Bill 220 to 215
- Stupak Amendment to Health Care Bill Passes 240 - 194 Saturday Evening
- Major Health Care Development - Pro-Life Stupak Amendment Vote OK'd for Today
- NY Times: Dems Banking on Later Squeezing Pro-Life Language Out of Bill in Committee
- USCCB Spokesman: "Definitely Not True" that Bishops Support Bill As it Stands
- TIME Got it Wrong - Prof. George Opposed Grandiose Kennedy Funeral
- USCCB Condemnation Tears Facade off "Phony" Abortion Compromise for Health Bill
- Health Care Bill Includes Monthly Abortion Premium: House Minority Leader Boehner
- TIME Article Setting Burke Against O'Malley Called "Tactical strike" on Behalf of Catholic Left
- Dirty Fighting on Abortion Funding: Word-Games and Health-Care Theatrics Boggle the Mind
- Commentary on November 6 News
- Note to LifeSiteNews Subscribers with Rogers email addresses
- New York Gov. Declares Nov. 10 Extraordinary Legislative Session for Same-Sex "Marriage"
- Washington's Pro-Family Amendment Effort Defeated - R-71 Almost Certain to Pass
- Vote Pushed Back on Canadian Euthanasia and Assisted Suicide Bill to Dec. 2
- Elderly U.K. Couple in Good Health Commit Suicide, Complain of Assisted Suicide Law
- Texas Late-Term Abortionist and Baptist Minister Admits: "Am I killing? Yes, I am"
- New Evidence Contradicts CCHD's Findings on Accused Pro-Abortion Partner
- Quebec Priest Denies Possibility of Sexual Reorientation Therapy on TV
- New Hampshire Same-Sex "Marriage" Law in Crosshairs after Maine's Law Crumbles
- Brooklyn Bishop Criticized for Recorded Message Praising Pro-Abortion Politician
- First Group of "Traditionalist" Anglicans in Britain Votes to Enter Catholic Church
Most Read this Week
- Planned Parenthood Director Resigns after Watching Ultrasound of Abortion Procedure
- Nun Defiant Following Rebuke, but Stops Abortion Escorting
- Breaking: Dominican Community Apologizes for Nun Caught Acting as Abortion Escort
- TIME Article Setting Burke Against O'Malley Called "Tactical strike" on Behalf of Catholics Left
- Over 200 Christendom College Students Protest Abortion at Planned Parenthood Clinic
- Newly Identified Corporate Supporters of Planned Parenthood Named
- Scottish Gay Rights Activists Found Guilty of Pedophilia Sentenced to Life Imprisonment
- US Congress Passes Health Care Reform Bill 218 to 215
- Major Health Care Bill Development - Stupak Hyde Amendment Vote OK'd
- Health Care Bill Includes Monthly Abortion Premium: House Minority Leader Boehner
MORE NEWS: 
LifeSiteNews.com Home Page Last 10 Days Archives Special Reports
Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.